Αποτελέσματα Αναζήτησης
17 Αυγ 2024 · Implement comprehensive management strategies for individuals with alpha-1 antitrypsin deficiency, including lifestyle modifications, smoking cessation interventions, vaccinations, and appropriate treatment options tailored to the specific manifestations of the disease.
20 Μαρ 2024 · Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder with an autosomal inheritance pattern and codominant expression of alleles. Allele mutations cause ineffective activity of alpha-1 antitrypsin, the enzyme responsible for neutralising neutrophil elastase.
Learn about Alpha-1, a genetic disorder that affects the protein that protects your lungs from damage. Find out how to diagnose, treat and prevent lung and liver complications caused by Alpha-1.
8 Απρ 2020 · Alpha1-antitrypsin (AAT) deficiency is one of the most common genetic diseases. Most persons carry two copies of the wild-type M allele of SERPINA1, which encodes AAT, and have normal...
Learn about the treatment options for AAT deficiency, a genetic condition that can cause lung and liver problems. Find out how augmentation therapy, medications, oxygen therapy, pulmonary rehabilitation and more can help you manage your symptoms and improve your quality of life.
At present there is only one disease-modifying pharmacological intervention available specifically for the treatment of alpha-1 antitrypsin deficiency (AATD): intravenous (IV) infusion of alpha-1 antitrypsin (AAT).
Alpha‐1 antitrypsin deficiency is an inherited disorder that can cause chronic obstructive pulmonary disease (COPD). People who smoke are more seriously affected and have a greater risk of dying from the disease. Therefore, the primary treatment is to help people give up smoking.
